7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrido[2,3-b]pyrazine → HCID 73058043, compound
Reaction equation
Br[C:2]1[NH:22][C:5]2=[N:6][CH:7]=[C:8]([CH2:10][CH2:11][C:12]3[CH:17]=[C:16]([O:18][CH3:19])[CH:15]=[C:14]([O:20][CH3:21])[CH:13]=3)[N:9]=[C:4]2[CH:3]=1.CC1(C)C(C)(C)OB([C:31]2[CH:40]=[N:39][C:34]3=[N:35][CH:36]=[CH:37][N:38]=[C:33]3[CH:32]=2)O1>>[CH3:21][O:20][C:14]1[CH:13]=[C:12]([CH:17]=[C:16]([O:18][CH3:19])[CH:15]=1)[CH2:11][CH2:10][C:8]1[N:9]=[C:4]2[CH:3]=[C:2]([C:31]3[CH:40]=[N:39][C:34]4=[N:35][CH:36]=[CH:37][N:38]=[C:33]4[CH:32]=3)[NH:22][C:5]2=[N:6][CH:7]=1Participants
3
Procedure
The compound was prepared by using procedures analogous to those described for the synthesis of Example 53, Step 2 starting from 6-bromo-2-[2-(3,5-dimethoxyphenyl)ethyl]-5H-pyrrolo[2,3-b]pyrazine and 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrido[2,3-b]pyrazine (from Combi-Blocks). LCMS calculated for C23H21N6O2(M+H)+: m/z=413.2. Found 413.2.
Workup
- customThe compound was prepared
Sources & evidence
- ORD record
- ord-0de21f786b974dcd93ed3c64004ba3df
- Source dataset
- uspto-grants-2016_07
- Patent number
- US09388185B2
Reaction notes
Loading…